Ligand Pharmaceuticals reported $72.86M in Gross Profit on Sales for its fiscal quarter ending in June of 2025.


Gross Profit On Sales Change Date
Amgen USD 6.17B 624M Jun/2025
Arrowhead Research 27.77M 514.94M Jun/2025
Baxter International USD 1.14B 283M Jun/2025
Bristol-Myers Squibb USD 8.9B 714M Jun/2025
Eli Lilly USD 13.11B 2.61B Jun/2025
Gilead Sciences USD 5.58B 453M Jun/2025
GlaxoSmithKline GBP 5.82B 229M Jun/2025
Glaxosmithkline GBP 5.83B 232M Jun/2025
Insmed USD 78.08M 6.53M Jun/2025
Ionis Pharmaceuticals USD 448M 317.85M Jun/2025
Ligand Pharmaceuticals USD 72.86M 32.38M Jun/2025
MacroGenics USD -27460000 41.32M Jun/2025
Merck USD 12.99B 224M Jun/2025
Pacira USD 125.91M 8.71M Jun/2025
Pfizer USD 10.88B 248M Jun/2025
Veracyte USD 89.77M 10.26M Jun/2025